Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC

Clinical Genetics

Volumn 71, Issue 2, 2007, Pages 158-164

  Bianchi, Francesca ^a   Galizia, E ^a   Bracci, R ^a   Belvederesi, L ^a   Catalani, R ^a   Loretelli, C ^a   Giorgetti, G ^a   Ferretti, C ^a   Bearzi, I ^a   Porfiri, E ^b   Cellerino, R ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Colorectal cancer; CRCAPRO; HNPCC; MMR

Indexed keywords

PROTEIN MLH1; PROTEIN MSH2;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL CANCER; COMPUTER PROGRAM; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; FRAMESHIFT MUTATION; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MICROSATELLITE INSTABILITY; MISSENSE MUTATION; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PROTEIN EXPRESSION; RELIABILITY; RISK ASSESSMENT; SAMPLE SIZE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

ADULT; AGED; CARRIER PROTEINS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DIAGNOSIS, COMPUTER-ASSISTED; DNA MISMATCH REPAIR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; HUMANS; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; SOFTWARE;

EID: 33846664995     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00746.x     Document Type: Article

References (26)

1. de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004: 4: 769-780.
2. de Jong AE, van Puijenbroek M, Hendriks Y et al. Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004: 10: 972-980.
3. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991: 34: 424-425.
4. Umar A, Risinger JI, Hawk ET, Barret JC. Testing guidelines for hereditary non-polyposis colorectal cancer. Nat Rev Cancer 2004: 4: 153-158.
5. Rodriguez-Bigas MA, Boland CR, Hamilton SR et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: Meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997: 89: 1758-1762.
6. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda guidelines for hereditary non polyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004: 96: 261-268.
7. Loukola A, Eklin K, Laiho P et al. Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 2001: 61: 4545-4549.
8. Lindor NM, Burgart LJ, Leontovich O et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumours. J Clin Oncol 2002: 20: 1043-1048.
9. de la Chapelle A. Microsatellite instability phenotype of tumours: genotyping or immunohistochemistry? The Jury Is Still Out. J Clin Oncol 2002: 20: 897-899.
10. Euhus DM, Cler L, Shivapurkar N et al. Loss of heterozygosity in benign breast epithelium in relation to breast cancer risk. J Natl Cancer Inst 2002: 94: 858-860.
11. Euhus DM. Understanding mathematical models for breast cancer risk assessment and counseling. Breast J 2001: 4: 224-232.
12. Marroni F, Pastrello C, Benatti P et al. A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. Clin Genet 2006: 69: 254-262.
13. Balmana J, Stockwell DH, Steyerberg EW et al. Prediction of MLH1 and MSH2 mutations in Lynch syndrome. JAMA 2006: 296: 1469-1478.
14. Scartozzi M, Bianchi F, Rosati S et al. Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression. J Clin Oncol 2002: 20: 1203-1208.
15. Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development on international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998: 58: 5248-5257.
16. Heinen CD, Wilson T, Mazurek A et al. HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions. Cancer Cell 2002: 1: 469-478.
17. Strate LL, Syngal S. Hereditary colorectal cancer syndromes. Cancer Causes Control 2005: 16: 201-213.
18. Merg A, Lynch HT, Lynch JF, Howe JR. Hereditary colorectal cancer-part II. Curr Probl Surg 2005: 42: 267-334.
19. Syngal S, Fox EA, Eng C et al. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000: 37: 641-645.
20. Pinol V, Castells A, Andreu M et al. Accuracy of revised Bethesda guidelines, microsatellite instability and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 2005: 293: 1986-1994.
21. Stormorken AT, Bowitz-Lothe IM, Noren T et al. Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005: 23: 4705-4712.
22. Baudhuin LM, Burgart LJ, Leontovich O, Thibodeau SN. Use of microsatellite instability and immunohistochemistry testing for the identification of individuals at risk for Lynch Syndrome. Fam Cancer 2005: 4: 255-265.
23. Wahlberg SS, Schmeits J, Thomas G et al. Evaluation of microsatellite instability and immunohistochemistry for the prediction of germline MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 2002: 62: 3485-3492.
24. American Society of Clinical Oncology. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J Clin Oncol 1996: 14: 1730-1736.
25. Wijnen JT, Vasen HF, Khan PM et al. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 1998: 339: 511-518.
26. Ainsworth PJ, Koscinski D, Fraser BP, Stuart JA. Family cancer histories predictive of a high risk of hereditary non-polyposis colorectal cancer associate significantly with a genomic rearrangement in hMSH2 or hMLH1. Clin Genet 2004: 66: 183-188.